BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29272004)

  • 1. Decreased expression of long non-coding RNA LINC00261 is a prognostic marker for patients with non-small cell lung cancer: a preliminary study.
    Liu Y; Xiao N; Xu SF
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5691-5695. PubMed ID: 29272004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
    Liao J; Dong LP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer.
    Wu B; Zhang XJ; Li XG; Jiang LS; He F
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3808-3812. PubMed ID: 28975987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
    Tian Y; Feng Y
    Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
    Qu CH; Sun QY; Zhang FM; Jia YM
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and diagnostic significance of long non-coding RNA AGAP2-AS1 levels in patients with non-small cell lung cancer.
    Fan KJ; Liu Y; Yang B; Tian XD; Li CR; Wang B
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2392-2396. PubMed ID: 28617550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
    Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
    Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
    Deng J; Liang Y; Liu C; He S; Wang S
    Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA HNF1A-AS1 up-regulation in non-small cell lung cancer correlates to poor survival.
    Ma YF; Liang T; Li CR; Li YJ; Jin S; Liu Y
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4858-4863. PubMed ID: 27981551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
    Wang H; Wang J; Liang CF; Zhou T
    Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer.
    Zhao QS; Li L; Zhang L; Meng XW; Li LL; Ge XF; Li ZP
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3031-4. PubMed ID: 27460731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation.
    Yu Y; Li L; Zheng Z; Chen S; Chen E; Hu Y
    J Cell Mol Med; 2017 May; 21(5):955-967. PubMed ID: 27878953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis.
    Wang T; Liu X; Tian Q; Liang T; Chang P
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3592-3597. PubMed ID: 28925485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.